查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198192

远程病人监护系统市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Remote Patient Monitoring Systems Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内，远程患者监护系统市场的复合年增长率为 8.54%。

COVID-19 大流行给全球人手不足和工作过度的医院和医疗保健系统带来了巨大压力。 远程患者监控技术对市场产生了积极影响，它允许患者在家中保持安全，同时减轻大流行期间医院、急诊室和一线医护人员的压力。 USFDA 颁布了新法规，允许医疗保健专业人员使用 FDA 批准的远程患者监测 (RPM) 设备来评估患者的体温、呼吸频率、心率和血压，而无需进行侵入性操作。 COVID-19 为临床医生和患者有效使用 RPM 奠定了坚实的基础。 根据 Jordan D. Coffey 在 NPJ Digital Medicine 上发表的 2021 年报告，RPM 技术在整个大流行期间的参与率为 78.9%。 大流行期间 RPM 设备的高利用率对所研究的市场产生了积极影响。 目前，市场对 RPM 设备的需求已达到大流行前的状态。 然而，预计未来几年将出现强劲增长。

推动市场发展的主要因素包括生活方式改变导致慢性病负担增加、人口迅速老龄化以及对家庭监控设备的需求不断增加。 远程患者监控是门诊医疗保健，患者使用移动医疗设备执行常规测试并将测试数据实时发送给医疗专业人员。

从全球角度来看，不断增加的慢性病人口、老龄化人口以及对家庭监控设备的需求正在推动市场增长。 例如，根据美国癌症协会2022年发布的年度报告，美国癌症新发病例数将达到190万左右，预计将有超过50万人死于癌症。 这种高癌症发病率和高死亡率可能会导致更多地使用监测设备来了解受影响个体的健康状况。 因此，由于癌症等慢性病的增加，预计该市场将出现显着增长。

这些设备还小巧便携，让患者可以全天佩戴而不会感到不适。 这些设备还确保持续监测患者的状况。 对家庭监控设备的需求不断增长也推动了市场增长。 根据 2021 年医疗保险和医疗补助服务中心的数据，远程监控器已帮助多名高危患者避免再次入院，并在家中过上更健康的生活。 使用远程监控的客户报告说再入院率降低了 76%，平均患者满意度为 89%，并节省了大约 3.7 亿美元的总医疗费用。

但是，医疗保健行业专业人士对引入监控系统的抵制、新兴市场对适当报销政策的需求以及严格的监管框架正在阻碍市场增长。

远程病人监护系统市场趋势

多参数监护仪领域有望在预测期内实现强劲增长

多参数监护仪是一种监测各种参数的设备，例如动脉血压、心率、体温/皮肤温度、血氧饱和度和二氧化碳图。 这些设备很受欢迎，因为它们体积小、便携且易于使用。 这些多参数远程监护设备被医疗专业人员和注重健康的个人使用，睡眠监测器和活动监测器也属于这些类别。 在发达国家和美国等新兴国家，慢性病死亡率不断上升，这提高了患者群体选择可以及早轻鬆监测的设备的意识。

市场参与者采取了各种策略，包括产品发布、产品开发、合作伙伴关係和扩张，以增加他们的市场份额。 例如，2022 年 4 月，新加坡品牌 BUZUD 復星商贸医疗推出了 BUZUD 多参数监护仪 (MPM)，旨在简化医疗监控流程并帮助医疗保健专业人员为患者提供更高水平的护理。并推出两款新的医疗设备，BUZUD PulseBit EX，一种价格适中且方便的心电图 (ECG) 个人追踪器，适用于心脏病患者。 此类产品的推出有望推动该细分市场的增长。

因此，人们越来越关注健康的生活方式，越来越关注对患者健康参数的持续监测，自我监测和预防医学的上升趋势预计将推动整个细分市场的增长。.

北美有望在预测期内对市场做出重大贡献

推动市场增长的主要因素包括慢性病负担加重、人口老龄化加剧、对无线和便携式系统的需求以及復杂的医疗报销系统。

新产品的推出是对北美地区市场增长做出重大贡献的主要因素。 例如，2022 年 5 月，Novant Health 与 Health Recovery Solutions 合作推出远程患者监护系统。 该合作伙伴关係将从一个针对肥胖患者的试点项目开始，併计划在未来几年内扩展到其他患者群体。

此外，该国的市场参与者已采取各种策略，例如产品发布、产品开发、合作伙伴关係和扩张，以增加其市场份额。 例如，2022 年 10 月，领先的最后一英里移动医疗服务提供商 DocGo 将在其与 Gary 和 Mary West PACE 的现有合作伙伴关係的基础上，在美国推出突破性的远程患者监护 (RPM) 解决方案。 2022年7月，瑞士医疗科技公司Sleepiz在美国食品药品监督管理局（FDA）註册了非接触式呼吸心率监测设备“Sleepiz One+”。 FDA 註册为 Sleepiz 在美国提供远程患者监测和临床试验解决方案铺平了道路。

因此，由于上述因素，预计北美地区将在预测期内实现增长。

远程病人监护系统市场竞争对手分析

远程患者监护系统市场较为分散。 市场上有各种医疗设备製造商和几家专业的远程病人监护设备製造商。 该行业竞争激烈，行业参与者和其他医疗设备製造商正在积极寻求合作伙伴关係和协议，以整合远程患者监控功能。 主要市场参与者包括 Abbott Laboratories、Aerotel Medical Systems、AMD Global Telemedicine、Baxter International Inc.、Boston Scientific Corporation、GE Healthcare、Masimo Corporation、Medtronic PLC、F. Hoffmann-La Roche AG、Omron Corporation 等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 生活方式的改变和老年人口的增加导致慢性病负担增加
    • 对家庭监控设备的需求不断扩大
    • 远程患者监护 (RPM) 设备的技术进步
  • 市场製约因素
    • 来自医疗保健行业专业人士的抵制
    • 严格的监管框架
    • 缺乏适当的报销
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按设备类型
    • 心臟监测器
    • 呼吸监测器
    • 血细胞计数器
    • 多参数监护仪
    • 其他
  • 通过申请
    • 癌症治疗
    • 心血管疾病
    • 糖尿病治疗
    • 睡眠障碍
    • 体重管理和健身监测
    • 其他应用
  • 最终用户
    • 家庭护理
    • 医院/诊所
    • 其他最终用户
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Abbott Laboratories
    • Aerotel Medical Systems
    • AMD Global Telemedicine
    • Baxter International Inc.
    • Boston Scientific Corporation
    • GE Healthcare
    • Masimo Corporation
    • Medtronic PLC
    • Omron Corporation
    • Philips Healthcare
    • OSI Systems Inc.
    • Dragerwerk AG & Co. KGaA
    • Compumedics Limited
    • Nihon Kohden Corporation
    • F. Hoffmann-La Roche AG

第七章市场机会与未来趋势

简介目录
Product Code: 56857

The remote patient monitoring systems market is expected to register a CAGR of 8.54% during the forecast period.

The COVID-19 pandemic placed enormous pressure on hospitals and healthcare systems that were understaffed and overworked globally. Remote patient monitoring technology helped patients remain safe within their homes while reducing stress on hospitals, emergency rooms, and front-line healthcare workers during the pandemic, thereby positively impacting the market. The USFDA established a new regulation allowing healthcare practitioners to use FDA-approved Remote Patient Monitoring (RPM) devices to assess patients' body temperature, respiration rate, heart rate, and blood pressure without invasive procedures. COVID-19 has provided a strong foundation for clinicians and patients to use RPM effectively. According to a report published in NPJ Digital Medicine in 2021 by Jordan D. Coffey, the RPM technology engagement rate was 78.9% throughout the pandemic. The market studied was positively impacted by the high utilization of RPM devices during the pandemic. Currently, the market has reached a pre-pandemic status in terms of demand for RPM devices. However, it is expected to witness strong growth in the coming years.

The major factors driving the market include the rising burden of chronic diseases due to lifestyle changes, the surge in the geriatric population, and the growing demand for home-based monitoring devices. Remote patient monitoring is ambulatory healthcare that allows patients to use a mobile medical device to accomplish a routine test and guide the test data to a healthcare expert in real time.

Globally, the rising chronic disease population, the increasing aging population, and the demand for home-based monitoring devices are boosting the market's growth. For instance, according to the American Cancer Society's annual report published in 2022, an estimated number of new cancer cases in the United States was believed to reach around 1.9 million, and over half a million people were expected to die due to cancer in the country. Owing to the high expected incidence of cancer and the high mortality, there will be growing use of monitoring devices to track health among the affected population. Hence, the market studied will be witnessing a strong growth due to the rising chronic diseases such as cancer.​

In addition, these devices are compact and portable, and patients can wear them all day without feeling uneasy. These devices also ensure that the patient's condition is monitored continuously. Growing demand for home-based monitoring devices also boosts the market's growth. According to the Center for Medicare and Medicaid Services in 2021, remote monitors help several high-risk patients avoid being readmitted to the hospital and make the most of their healthy days at home. Clients who use remote monitoring report a 76% reduction in readmission rates, an average of 89% patient satisfaction, and a total medical cost savings of nearly USD 370 million.

However, healthcare industry professionals' resistance to adopting monitoring systems, a need for proper reimbursement policies in developed markets, and the stringent regulatory framework impede the market's growth.

Remote Patient Monitoring Systems Market Trends

The Multi-parameter Monitors Segment is Expected to Register Significant Growth over the Forecast Period

Multi-parameter monitors are devices with a single device that monitors various parameters, such as arterial blood pressure, heart rate, body and skin temperature, oximetry, and capnography. These devices have become popular as they are small, portable, and user-friendly. These multi-parameter remote monitoring devices are used by medical professionals and the health-conscious population, as sleep and activity monitors fall into these categories. The increased death rate due to chronic diseases across developed countries, such as the United States, and developing countries, has raised awareness among the patient population to opt for early and easy-to-monitor devices.

The market players adopted various strategies, such as product launches, product developments, collaborations, and expansions, to increase their market share. For instance, in April 2022, Singapore brand BUZUD, Fosun Trade Medical Device, launched two new medical devices, namely the BUZUD Multi-Parameter Monitor (MPM), designed to streamline the medical monitoring process and help healthcare professionals provide a higher level of care to their patients, and the BUZUD PulseBit EX, a personal electrocardiogram (ECG) tracker that makes heart care affordable and convenient for heart patients. Such launches are expected to propel the growth of the market segment.

Therefore, the rising focus on a healthy lifestyle, increasing concerns about the constant monitoring of patients' health parameters, and the growing trend of self-monitoring and preventive medicine are expected to drive the growth of the overall market segment.

North America is Expected to be the Major Contributor to the Market over the Forecast Period

The major factors driving the market's growth include the growing burden of chronic diseases, an increasing geriatric population, demand for wireless and portable systems, and a sophisticated reimbursement structure.

New product launches are a major factor contributing significantly to the market growth in the North American region. For instance, in May 2022, Novant Health launched a remote patient monitoring system in partnership with Health Recovery Solutions. The partnership was launched with a pilot program focused on bariatric patients, with plans to expand to other patient populations in the coming years.

Furthermore, the market players in the country adopted various strategies such as product launches, product developments, collaborations, and expansions to increase their market share. For instance, in October 2022, DocGo, a leading provider of last-mile mobile health services, announced that it would build upon its existing partnership with Gary and Mary West PACE and introduce a revolutionary remote patient monitoring (RPM) solution in the United States. In addition, in July 2022, Switzerland-based medical technology company Sleepiz registered its Sleepiz One+ contactless respiration and heart rate measuring device with the United States Food and Drug Administration (FDA). The FDA listing paved the way for Sleepiz to offer its solution for remote patient monitoring and clinical trials in the United States.

Therefore, the North American region is expected to register growth over the forecast period due to the abovementioned factors.

Remote Patient Monitoring Systems Market Competitor Analysis

The remote patient monitoring systems market is moderately fragmented. Various medical device manufacturers and several specialized remote patient monitoring equipment manufacturers are operating in the market. The industry is highly competitive, and there is a growing trend of partnerships and agreements between industry participants and other medical device manufacturers to incorporate remote patient monitoring functionalities. Some key market players include Abbott Laboratories, Aerotel Medical Systems, AMD Global Telemedicine, Baxter International Inc., Boston Scientific Corporation, GE Healthcare, Masimo Corporation, Medtronic PLC, F. Hoffmann-La Roche AG, and Omron Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases Due to Lifestyle Changes and Increasing Geriatric Population
    • 4.2.2 Growing Demand for Home-based Monitoring Devices
    • 4.2.3 Technological Advancements in Remote Patient Monitoring (RPM) Devices
  • 4.3 Market Restraints
    • 4.3.1 Resistance from Healthcare Industry Professionals
    • 4.3.2 Stringent Regulatory Framework
    • 4.3.3 Lack of Proper Reimbursement
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Device
    • 5.1.1 Heart Monitors
    • 5.1.2 Breath Monitors
    • 5.1.3 Hematology Monitors
    • 5.1.4 Multi-parameter Monitors
    • 5.1.5 Other Types of Devices
  • 5.2 By Application
    • 5.2.1 Cancer Treatment
    • 5.2.2 Cardiovascular Diseases
    • 5.2.3 Diabetes Treatment
    • 5.2.4 Sleep Disorder
    • 5.2.5 Weight Management and Fitness Monitoring
    • 5.2.6 Other Applications
  • 5.3 By End-User
    • 5.3.1 Home Care Settings
    • 5.3.2 Hospitals/Clinics
    • 5.3.3 Other End-Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Aerotel Medical Systems
    • 6.1.3 AMD Global Telemedicine
    • 6.1.4 Baxter International Inc.
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 GE Healthcare
    • 6.1.7 Masimo Corporation
    • 6.1.8 Medtronic PLC
    • 6.1.9 Omron Corporation
    • 6.1.10 Philips Healthcare
    • 6.1.11 OSI Systems Inc.
    • 6.1.12 Dragerwerk AG & Co. KGaA
    • 6.1.13 Compumedics Limited
    • 6.1.14 Nihon Kohden Corporation
    • 6.1.15 F. Hoffmann-La Roche AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS